Photodynamic therapy trials with Lutetium Texaphyrin (Lu-Tex) in patients with locally recurrent breast cancer

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 3247, Issue , 1998, Pages 35-39

  Renschler, Markus F ^a   Yuen, Alan R ^a   Panella, Timothy J ^a   Wieman, T Jeffrey ^a   Dougherty, Shona ^a   Esserman, Laura ^a   Panjehpour, Masoud ^a   Taber, Scott W ^a   Fingar, Victor H ^a   Lowe, Elizabeth ^a   Engel, Julie S ^a   Lum, Bert ^a   Woodburn, Kathryn W ^a   Cheong, Wei Fung ^a   Miller, Richard A ^a  

^a PHARMACYCLICS INC   (United States)

Author keywords

Breast cancer; Cancer; Clinical trials; Cutaneous tumors; Human; Laser; Light emitting diode (LED); Lu Tex; Lutetium Texaphyrin; Photodynamic therapy (PDT); Photosensitizer; Subcutaneous tumors

Indexed keywords

LIGHT EMITTING DIODES; OPTIMIZATION; PHOTOSENSITIZERS; RADIOTHERAPY; TOXICITY; TUMORS;

CUTANEOUS TUMORS;

PHOTODYNAMIC THERAPY;

EID: 0346982147     PISSN: 0277786X     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.308147     Document Type: Conference Paper

References (8)

1. Cancer statistics 1996
2. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer
3. Local or regionally recurrent carcinoma of the breast: Results of therapy in 121 patients
4. Results of irradiation in the treatment of locoregional breast cancer recurrence
5. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy
6. Lutetium texaphyrin (PCI-0123): A near-infrared water-soluble photosensitizer
7. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model
8. Light emitting diode versus laser irradiation phototherapy with lutetium texaphyrin (PCI-0123)